This analysis underscores the importance of multiple immunomodulatory proteins, particularly CD27, KLRB1, RETN, and CD163, in the risk of clinically overt sepsis, suggesting their potential as candidates for disease prognosis and treatment targets (Table 3). This evidence concerns the gene CD163 and Sepsis.